David C. Litzinger
17Patents
8h-index
34Co-inventors
68Inventor score
Filing activity: Jan 28, 2005 → Jan 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7638299B2 | Biosynthetic polypeptides utilizing non-naturally encoded amino acids | Chemistry; Metallurgy | 47 | Expired |
| US7816320B2 | Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 | Human Necessities | 30 | Active |
| US8778880B2 | Human growth hormone modified at position 35 | Physics | 21 | Active |
| US7939496B2 | Modified human growth horomone polypeptides and their uses | Human Necessities | 19 | Active |
| US8093356B2 | Pegylated human interferon polypeptides | Human Necessities | 19 | Active |
| US8178494B2 | Modified human growth hormone formulations with an increased serum half-life | Human Necessities | 18 | Active |
| US8163695B2 | Formulations of human growth hormone comprising a non-naturally encoded amino acid | Human Necessities | 17 | Active |
| US8143216B2 | Modified human growth hormone | Human Necessities | 17 | Active |
| US8906676B2 | Modified human four helical bundle polypeptides and their uses | Physics | 3 | Active |
| US9382304B2 | Engineered polypeptides having enhanced duration of action with reduced immunogenicity | Chemistry; Metallurgy | 3 | Active |
| US8907064B2 | Modified human four helical bundle polypeptides and their uses | Physics | 3 | Active |
| US9260472B2 | Modified human four helical bundle polypeptides and their uses | Physics | 2 | Active |
| US9593154B2 | Engineered polypeptides having enhanced duration of action | Chemistry; Metallurgy | 2 | Active |
| US9879063B2 | Engineered polypeptides having enhanced duration of action and reduced immunogenicity | Chemistry; Metallurgy | 1 | Active |
| US11535659B2 | Engineered polypeptides having enhanced duration of action | Chemistry; Metallurgy | 0 | Active |
| US11596648B2 | Emollient topical disinfectants | Emerging Cross-Sectional Technologies | 0 | Active |
| US11446307B2 | Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.